USE OF GLYCOMACROPEPTIDE TO IMPROVE WOMEN'S HEALTH
First Claim
1. A method for improving the health of a female human or non-human animal comprising administering to the animal an effective amount of a composition comprising glycomacropeptide (GMP), whereby one or more of the following occurs:
- (a) the rate of fat oxidation or fat metabolism in the animal is increased;
(b) the percentage of body fat in the animal is reduced;
(c) the rate of bone mineralization in the animal is increased;
(d) the bone mineral content or bone mineral density in the animal is increased;
or(e) the bone strength in the animal is increased.
1 Assignment
0 Petitions
Accused Products
Abstract
Methods for improving the health of a female human or non-human animal are disclosed. The methods include the step of administering to the animal compositions including an effective amount of glycomacropeptide (GMP) for effectuating the methods. Specifically, the methods can be used to increase the rate of fat metabolism or fat oxidation, decrease percentage of body fat, increase the rate of bone mineralization, increase bone mineral content, increase bone mineral density, and/or increase bone strength in the animal.
GMP-containing compositions can be used according to the disclosed methods to treat obesity and related metabolic conditions, or to treat or prevent osteoporosis, osteopenia, and other conditions related to loss of bone mineral content or bone strength.
3 Citations
10 Claims
-
1. A method for improving the health of a female human or non-human animal comprising administering to the animal an effective amount of a composition comprising glycomacropeptide (GMP), whereby one or more of the following occurs:
-
(a) the rate of fat oxidation or fat metabolism in the animal is increased; (b) the percentage of body fat in the animal is reduced; (c) the rate of bone mineralization in the animal is increased; (d) the bone mineral content or bone mineral density in the animal is increased;
or(e) the bone strength in the animal is increased. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10)
-
Specification